Status:
COMPLETED
Study to Learn More About the Stomach and Intestine Complaints of Children Aged From 3 to 14 Years
Lead Sponsor:
Bayer
Conditions:
Functional Gastrointestinal Disorders
Eligibility:
All Genders
3-14 years
Brief Summary
In this observational study, researchers want to gain more information on children suffering from abnormal stomach and intestine function (based on the Rome criteria) and treated Iberogast. The Rome c...
Eligibility Criteria
Inclusion
- The selection of the children to be documented was the sole responsibility of the physician whereby the information of the Rome III criteria on functional gastrointestinal diseases in children as well as the prescribing information on Iberogast could be consulted as guideline. Only the therapeutic necessity was determining for the use of all medicines. The treating physicians received standardised information regarding the ailment picture (Rome III criteria) before the beginning of the study and during the investigator meetings.
Exclusion
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
1032 Patients enrolled
Trial Details
Trial ID
NCT04029376
Start Date
April 1 2007
End Date
October 1 2008
Last Update
September 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many locations
Multiple Locations, Germany